CCR2 and neuroblastoma: All three of these chemokines are ligands for the CCR2 receptor, thus when CCR2b was transduced together with a CAR specific for GD2 into human T cells, these modified T cells showed enhanced trafficking with >10-fold improved homing to CCL2-secreting neuroblastoma, and significantly enhanced activity against neuroblastoma xenografts in vivo (166).